BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 418183)

  • 1. Isolation and metastatic properties of detachment variants of B16 melanoma cells.
    Briles EB; Kornfeld S
    J Natl Cancer Inst; 1978 Jun; 60(6):1217-22. PubMed ID: 418183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
    Baniyash M; Netanel T; Witz IP
    Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.
    Poste G; Doll J; Fidler IJ
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6226-30. PubMed ID: 6947225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW; Nicolson GL
    J Supramol Struct; 1979; 11(4):517-28. PubMed ID: 544929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional emergence of metastatic heterogeneity in a growing tumor.
    Raz A
    Cancer Lett; 1982; 17(2):153-60. PubMed ID: 7165871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
    Yamamura K; Kibbey MC; Kleinman HK
    Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selection and characterization of an invasive variant of the B16 melanoma.
    Hart IR
    Am J Pathol; 1979 Dec; 97(3):587-600. PubMed ID: 507192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan production and distribution in cloned B16 murine melanoma cell lines exhibiting different lung colony-forming efficiencies.
    Maniglia CA; Gomez JJ; Luikart SD; Sartorelli AC
    J Natl Cancer Inst; 1985 Jul; 75(1):111-20. PubMed ID: 3925212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis results from preexisting variant cells within a malignant tumor.
    Fidler IJ; Kripke ML
    Science; 1977 Aug; 197(4306):893-5. PubMed ID: 887927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW; Alterman AL; Fornabaio DM
    Invasion Metastasis; 1985; 5(3):125-43. PubMed ID: 3888909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in growth inhibition by beta-trans-retinoic acid of metastatic B16 melanoma clones and in vivo-selected cell variant lines.
    Lotan R; Nicolson GL
    Cancer Res; 1979 Dec; 39(12):4767-71. PubMed ID: 498105
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of B16 melanoma cells with increased metastatic potential and low intercellular cohesion using Nuclepore filters.
    Tullberg KF; Burger MM
    Invasion Metastasis; 1985; 5(1):1-15. PubMed ID: 3980159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of tumor takes to B16 melanoma in C57BL/6J mice injected with B16 products.
    Kalish R; Brody NI
    J Invest Dermatol; 1980 Sep; 75(3):275-8. PubMed ID: 7190993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors.
    Tsuruo T; Yamori T; Naganuma K; Hori K; Kawabata H; Tsukagoshi S; Sakurai Y
    Gan; 1984 Feb; 75(2):193-8. PubMed ID: 6735031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.